Live feed
Filing
SC 13D/A
SC 13D/A0001062993-21-001180·Advent Life Sciences LLP
Schedule 13D ownership disclosure
ITERUM THERAPEUTICS PLC SHS NEW
Security class unavailable · CUSIP: G6333L101
Event date: 2021-01-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,859,173
- Percent of class
- 3.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-21-001180
- Form type
- SC 13D/A
- Filer
- Advent Life Sciences LLP
- CIK
- CIK 1601364
- Filed
- Feb 10, 2021
- Reporting period
- Jan 31, 2021
- Description
- Schedule 13D beneficial ownership